礼来Eli Lilly & Co. (LLY) 2004年年度报告「NYSE」.pdf

1、Eli Lilly and Company2004 Annual ReportNotice of 2005 Annual Meetingand Proxy StatementAnswers for Shareholders 2004Eli Lilly and CompanyLilly Corporate CenterIndianapolis,Indiana 46285 USA 2005 Eli Lilly and Company 500002RLillyA or call toll-free 1-877-RX-LILLYLilly C or call toll-free 1-800-545-6

2、962Lilly corporate reform.www.cms.hhs.gov/medicarereformPharmaceutical industry patient assistance programs.www.pparx.orgYear in Review 1 Financial Highlights 2 Letter to Shareholders 6 A Pipeline of Innovation at Lilly 8 Lilly:A Good Corporate CitizenFinancials 9 Review of Operations 15 Consolidate

3、d Statements of Income 17 Consolidated Balance Sheets 25 Consolidated Statements of Cash Flows 26 Consolidated Statements of Comprehensive Income 27 Segment Information 28 Selected Quarterly Data 29 Selected Financial Data 30 Notes to Consolidated Financial Statements 49 Managements Report on Intern

4、al Control Over Financial Reporting 50 Report of Independent Registered Public Accounting FirmProxy Statement 52 Notice of 2005 Annual Meeting and Proxy Statement 54 General Information 58 Board of Directors 62 Highlights of the Companys Corporate Governance Guidelines 67 Audit Committee Matters 69

5、Executive Compensation 77 Performance Graph 78 Ownership of Company Stock 79 Items of Business To Be Acted Upon at the Meeting 88 Other Matters 89 AppendicesCorporate Information 92 Senior Management 93 Corporate Information 94 Trademarks 95 Annual Meeting Admission Ticket12004 Financial HighlightsE

6、LI LILLY AND COMPANY AND SUBSIDIARIES(Dollars in millions,except per-share data)Year Ended December 31 2004 2003 Change%Net sales.$13,857.9$12,582.5 10Research and development .2,691.1 2,350.2 15Research and development as a percent of sales .19.4%18.7%Net income .$1,810.1$2,560.8(29)Earnings per sh